|
| Agrenvec |
|
 |
|
 |
|
|
| |
AGRENVEC – about company.
Agrenvec is a European biotech specialized in plant production of mammalian recombinant proteins and antibodies for the R&D market. Was created as a start-up company in 2002 with the in-licensing of several patents from the INIA (Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria).
They are focused on the development, manufacture and marketing, of products and services for the R&D and Industrial markets. Their Company owns a patented technology platform allowing them a high-throughput production of Animal free fully active recombinant proteins with complex 3D structure and with a purity of 97%.
Supported by a multi-disciplinary group of experts with an extensive professional career, Agrenvec is one of the few companies in the world capable of using the viral vectors technology to turn plants into bio-factories. It counts with a stable work team of fourteen highly qualified professionals, 30% of their personnel have a PhD and 60% a university degree. Their manager team has a long experience in the pharmaceutical and biotechnological industry.
Their main offices and laboratories are located in the Parque Científico de Madrid. Their facilities are equipped with the latest technology in genetic engineering, purification of proteins including last generation ÄKTA Explorer, ÄKTA Express, phytotron and greenhouse for plant production and complete equipped molecular laboratory.
Agrenvec has developed unique purification protocols that combined with their technology platform enable them to produce recombinant proteins very competitively. They have accumulated a deep know-how in industrial production of recombinant proteins and antibodies. After several years of experience they control the whole value chain, from the bench to the final product, thanks to their highly qualified team. Their production system, compared to transgenic plants, is more efficient and flexible, faster and cheaper. Its scaling up is easier and linear; they obtain from milligrams to kilograms of the protein of interest.
Agrenvec is client-focused, so they adapt to their customer needs in all their projects.
Some of their projects have been co-founded by the Spanish Ministry of Science, and other public organizations, such as Innovation Department of Madrid Regional Government, Ministerio de Economía y Competitividad, CDTI, ENISA, Genoma España.
VISION
Their vision is to be the leading company commercializing recombinant proteins and antibodies for the R&D market. To be the first to bring to the market recombinant proteins produced in a 100% animal-free non-transgenic-plant system.
MISSION
Their mission is to guarantee their customer´s 100% satisfaction producing for them the best recombinant proteins and antibodies in the market; to study any project to produce any protein, suggested by their clients.
PRODUCT Lines:
> Clean Antibodies:
- Anti-Human Polyclonal IgG
- Anti-Human Polyclonal Serum
> Easy Blot Mini Kit:
- Easy Blot Mini Skits
- Easy Blot Mini YKits
> Human Recombinant Proteins:
- Animal-Free Cytokines
- Growth Factors & Cytokines
- Other Proteins
Applications:
- Cell Culture
- ELISA
- Immunogen
- Neutralization
- Proliferation, Diferenciation & cellular maintenance
- Western Blot
Research Areas:
- Cancer
- Cardiovascular
- Cell Biology
- Developmental Biology
- Epithelial Biology
- Immunology
- Neurobiology
- Pathways and Processes
- Stem Cells & Differentiation
SERVICES:
They are specialists in protein production and antibody generation. They have a large experience in cytokines, interleukins and growth factors production and as well in antibodies for R&D.
The service they perform are:
- Recombinant Protein custom project
- Polyclonal Antibody Production
|
|
| Displaying 1 to 5 (of 40 products) |
Result Pages: 1 |
|
|
|
|
|
